Article: Xenical(R) Shown to Improve Control of Blood Glucose Levels in People With Type 2 Diabetes Beyond Impact of Weight Loss Alone.

Sydney, AUSTRALIA, September 7 /PRNewswire/ --

- First Study to Demonstrate Independent Effect of Xenical on Glycaemic Control

The weight loss medication Xenical(R) (orlistat) has been shown to significantly reduce weight and improve the control of glucose levels in the blood (glycaemia) beyond the impact of weight loss alone in overweight and obese people with type 2 diabetes, according to study results presented at the International Congress on Obesity (ICO) in Sydney, Australia[1].

An analysis measuring the change in blood glucose levels vs. weight at study end point confirmed that the improvement in glycaemic control with Xenical was ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!